# Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-tolerability-and-effectiveness-of-the-sodium-glucose-cotransporter-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lauren K. Park,Kian‐Huat Lim,J. L. Volkman,Mina Abdiannia,Hannah Johnston,Zack Nigogosyan,Marilyn J. Siegel,Janet B. McGill,Alexis M. McKee,Maamoun Salam,Rong M. Zhang,Da Ma,Karteek Popuri,Vincent Chow,Mirza Faisal Beg,William G. Hawkins,Linda R. Peterson,Joseph E. Ippolito |
| Citations | 30 |
| DOI | 10.1186/s40170-023-00306-2 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://cancerandmetabolism.biomedcentral.com/counter/pdf/10.1186/s40170-023-00306-2 |
| OpenAlex ID | https://openalex.org/W4377093889 |
| PMID | 37202813 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Zack Nigogosyan](https://scholariq.org/researchers/zack-nigogosyan/)

## Paper primary topic

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

## Paper topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Pancreatitis Pathology and Treatment](https://scholariq.org/topics/pancreatitis-pathology-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.